Omicron’s surge helped clarify the Pfizer vaccine’s efficacy in young children, a company board member says. by BY MATT RICHTEL


At the urging of the federal government, Pfizer and its partner BioNTech applied last week for authorization for two doses of its Covid vaccine to children aged 4 and younger.

Published: February 6, 2022 at 07:27PM

from NYT Health https://ift.tt/Sp04GUA